You just read:

Blueprint Medicines to Present Preliminary Data from Ongoing Phase 1 Clinical Trials for BLU-285 and BLU-554 at 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

News provided by

Blueprint Medicines

Nov 15, 2016, 06:00 ET